FIG. 1.
Typical human cumulative AUC0-24 following a 400-mg dose of gatifloxacin (dashed line) and murine cumulative AUC0-24 (solid line) representative of those for mice given a regimen designed to mimic the cumulative exposure in humans.
Typical human cumulative AUC0-24 following a 400-mg dose of gatifloxacin (dashed line) and murine cumulative AUC0-24 (solid line) representative of those for mice given a regimen designed to mimic the cumulative exposure in humans.